Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cardiomyopathies × Valsartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urologic Diseases 1 Nephritis 1 Lymphoma, Non-Hodgkin 1 Kidney Diseases 1 Immune System Diseases 1 Heart Failure 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Cardiomyopathies 1 Autoimmune Diseases 1

Interventions

epicatechin gallate 1 Valsartan 1 Therapeutics 1 Standard of Care 1 Restraint, Physical 1 Practice Guidelines as Topic 1 Mesenchymal Stem Cell Transplantation 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00162955 2012-05-08

Prevention of CHOP-induced Chronic Cardiotoxicity

Osaka City University

Phase 4 Completed

Lymphoma, Non-Hodgkin, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡